Defective ribosome assembly in Shwachman-Diamond syndrome

Blood

Volumn 118, Issue 16, 2011, Pages 4305-4312

  Wong, Chi C ^a,b   Traynor, David ^a   Basse, Nicolas ^a,b   Kay, Robert R ^a   Warren, Alan J ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR 1; EUKARYOTIC INITIATION FACTOR 6; INITIATION FACTOR; INTEIN; UNCLASSIFIED DRUG;

ARTICLE; DICTYOSTELIUM DISCOIDEUM; DISEASE ASSOCIATION; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LYMPHOBLAST; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RIBOSOME SUBUNIT; SBDS GENE; SHWACHMAN SYNDROME; TEMPERATURE SENSITIVE MUTANT;

EID: 80054836766     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-353938     Document Type: Article

References (36)

1. Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003;33(1):97-101. (Pubitemid 36068690)
2. Donadieu J, Leblanc T, Bader Meunier B, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica. 2005;90(1):45-53. (Pubitemid 40193753)
3. Zhang S, Shi M, Hui CC, Rommens JM. Loss of the mouse ortholog of the shwachman-diamond syndrome gene (Sbds) results in early embryonic lethality. Mol Cell Biol. 2006;26(17):6656-6663. (Pubitemid 44277900)
4. Shammas C, Menne TF, Hilcenko C, et al. Structural and mutational analysis of the SBDS protein family. Insight into the leukemia-associated Shwachman-Diamond Syndrome. J Biol Chem. 2005;280(19):19221-19229. (Pubitemid 41379629)
5. Savchenko A, Krogan N, Cort JR, et al. The Shwachman-Bodian-Diamond syndrome protein family is involved in RNA metabolism. J Biol Chem. 2005;280(19):19213-19220. (Pubitemid 41379628)
6. Ng CL, Waterman DG, Koonin EV, et al. Conformational flexibility and molecular interactions of an archaeal homologue of the Shwachman-Bodian-Diamond syndrome protein. BMC Struct Biol. 2009;9:32.
7. Finch AJ, Hilcenko C, Basse N, et al. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev. 2011;25(9):917-929.
8. KuijpersTW, Alders M, ToolAT, Mellink C, Roos D, Hennekam RC. Hematologic abnormalities in Shwachman Diamond syndrome: lack of genotype-phenotype relationship. Blood. 2005;106(1):356-361. (Pubitemid 40967213)
9. Stepanovic V, Wessels D, Goldman FD, Geiger J, Soll DR. The chemotaxis defect of Shwachman-Diamond Syndrome leukocytes. Cell Motil Cytoskeleton. 2004;57(3):158-174. (Pubitemid 38263868)
10. Austin KM, Gupta ML, Coats SA, et al. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest. 2008;118(4):1511-1518. (Pubitemid 351500444)
11. Ball HL, Zhang B, Riches JJ, et al. Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses. Hum Mol Genet. 2009;18(19):3684-3695.
12. Ganapathi KA, Austin KM, Lee CS, et al. The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood. 2007;110(5):1458-1465. (Pubitemid 47443960)
13. Menne TF, Goyenechea B, Sanchez-Puig N, et al. The Shwachman-Bodian- Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat Genet. 2007;39(4):486-495. (Pubitemid 46514776)
14. Basu U, Si K, Warner JR, Maitra U. The Saccharomyces cerevisiae TIF6 gene encoding translation initiation factor 6 is required for 60S ribosomal subunit biogenesis. Mol Cell Biol. 2001; 21(5):1453-1462. (Pubitemid 32156365)
15. Gartmann M, Blau M, Armache JP, Mielke T, Topf M, Beckmann R. Mechanism of eIF6-mediated inhibition of ribosomal subunit joining. J Biol Chem. 2010;285(20):14848-14851.
16. Senger B, Lafontaine DL, Graindorge JS, et al. The nucle(ol)ar Tif6p and Efl1p are required for a late cytoplasmic step of ribosome synthesis. Mol Cell. 2001;8(6):1363-1373. (Pubitemid 34085005)
17. Becam AM, Nasr F, Racki WJ, Zagulski M, Herbert CJ. Ria1p (Ynl163c), a protein similar to elongation factors 2, is involved in the biogenesis of the 60S subunit of the ribosome in Saccharomyces cerevisiae. Mol Genet Genomics. 2001; 266(3):454-462. (Pubitemid 33030316)
18. Johnson AW, Ellis SR. Of blood, bones, and ribosomes: is Swachman-Diamond syndrome a ribosomopathy? Genes Dev. 2011;25(9):898-900.
19. Watts DJ, Ashworth JM. Growth of myxameobae of the cellular slime mould Dictyostelium discoideum in axenic culture. Biochem J. 1970;119(2): 171-174.
20. Kay RR. Cell differentiation in monolayers and the investigation of slime mold morphogens. Methods Cell Biol. 1987;28:433-448.
21. Hoeller O, Kay RR. Chemotaxis in the absence of PIP3 gradients. Curr Biol. 2007;17(9):813-817. (Pubitemid 46635122)
22. Zeidler MP, Tan C, Bellaiche Y, et al. Temperature-sensitive control of protein activity by conditionally splicing inteins. Nat Biotechnol. 2004; 22(7):871-876. (Pubitemid 38886607)
23. Alton TH, Lodish HF. Developmental changes in messenger RNAs and protein synthesis in Dictyostelium discoideum. Dev Biol. 1977;60(1):180-206.
24. Dror Y, Ginzberg H, Dalal I, et al. Immune function in patients with Shwachman-Diamond syndrome. Br J Haematol. 2001;114(3):712-717. (Pubitemid 32953656)
25. Boria I, Garelli E, Gazda HT, et al. The ribosomal basis of Diamond-Blackfan anemia: mutation and database update. Hum Mutat. 2010;31(12):1269-1279.
26. Boultwood J, Pellagatti A, Cattan H, et al. Gene expression profiling of CD34+ cells in patients with the 5q-syndrome. Br J Haematol. 2007; 139(4):578-589. (Pubitemid 350043812)
27. Ebert BL, Pretz J, Bosco J, et al. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature. 2008;451(7176):335-339.
28. Barlow JL, Drynan LF, Hewett DR, et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome. Nat Med. 2010;16(1):59-66.
29. Jones NC, Lynn ML, Gaudenz K, et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med. 2008;14(2):125-133. (Pubitemid 351214559)
30. McGowan KA, Li JZ, Park CY, et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet. 2008;40(8):963-970.
31. Barlow JL, Drynan LF, Trim NL, Erber WN, Warren AJ, McKenzie AN. New insights into 5q-syndrome as a ribosomopathy. Cell Cycle. 2010; 9(21):4286-4293.
32. Macias E, Jin A, Deisenroth C, et al. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell. 2010;18(3):231-243.
33. Elghetany MT, Alter BP. p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. Arch Pathol Lab Med. 2002;126(4):452-455. (Pubitemid 34286811)
34. Dror Y. P53 protein overexpression in Shwachman-Diamond syndrome. Arch Pathol Lab Med. 2002; 126(10):1157-1158, author reply 1158.
35. Rajpar MH, McDermott B, Kung L, et al. Targeted induction of endoplasmic reticulum stress induces cartilage pathology. PLoS Genet. 2009; 5(10):e1000691.
36. Urushihara H, Morio T, Tanaka Y. The cDNA sequencing project. Methods Mol Biol. 2006;346: 31-49.